Acute ischemic stroke. New approaches to antithrombotic treatment;Akuter ischämischer schlaganfall: Neue ansätze in der antithrombosetherapie

Nervenarzt

Volumn 83, Issue 4, 2012, Pages 435-449

  Kraft, P ^a   Nieswandt, B ^b   Stoll, G ^a   Kleinschnitz, C ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Hemorrhage; Hemostasis; Platelets; Stroke; Thrombus

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 12A; THROMBIN RECEPTOR;

ARTERY EMBOLISM; ARTERY THROMBOSIS; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BLOOD CLOTTING; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; HEMOSTASIS; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LUNG EMBOLISM; NONHUMAN; STROKE; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOGENESIS; TRANSGENIC MOUSE;

ACUTE DISEASE; ANIMALS; ANTICOAGULANTS; BRAIN ISCHEMIA; FIBRINOLYTIC AGENTS; HUMANS; MICE; MICE, TRANSGENIC; STROKE; THROMBOLYTIC THERAPY;

EID: 84863090181     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-011-3368-6     Document Type: Article

References (84)

1. Adams HP Jr, Effron MB, Torner J et al (2008) Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 39:87-99
2. Al-Tamimi M, Gardiner EE, Thom JY et al (2011) Soluble glycoprotein VI is raised in the plasma of patients with acute ischemic stroke. Stroke 42:498-500
3. Baker RI, Eikelboom J, Lofthouse E et al (2001) Platelet glycoprotein Ibalpha Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood 98:36-40
4. Berger C, Stauder A, Xia F, Sommer C (2007) Neuroprotection and glutamate attenuation by acetylsalicylic acid in temporary but not in permanent cerebral ischemia. Exp Neurol 210:543-548
5. Berger C, Xia F, Schäbitz WR et al (2004) High-dose aspirin is neuroprotective in a rat focal ischemia model. Brain Res 998:237-242 (Pubitemid 38125065)
6. Bergmeier W, Schulte V, Brockhoff G et al (2002) Flow cytometric detection of activated mouse integrin alphaIIbbeta3 with a novel monoclonal antibody. Cytometry 48:80-86 (Pubitemid 34591919)
7. Berndt MC, Shen Y, Dopheide SM et al (2001) The vascular biology of the glycoprotein Ib-IX-V complex. Thromb Hemost 86:178-188 (Pubitemid 32663951)
8. Bhatt DL, Topol EJ (2003) Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov 2:15-28 (Pubitemid 37361621)
9. Bongers TN, Maat MP de, Goor ML van et al (2006) High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Stroke 37:2672-2677 (Pubitemid 44922524)
10. Bousser MG, Amarenco P, Chamorro A et al (2011) Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet 377:2013-2022
11. Bräuninger S, Kleinschnitz C (2009) Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems. Exp Transl Stroke Med 25(1):8
12. Braun A, Varga-Szabo D, Kleinschnitz C et al (2009) Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation. Blood 113:2056-2063
13. CAST (Chinese Acute Stroke Trial) Collaborative Group (1997) CAST: randomised placebo-controlled trial of early aspirin use in 20, 000 patients with acute ischaemic stroke. Lancet 349:1641-1649
14. Choudhri TF, Hoh BL, Prestigiacomo CJ et al (1999) Targeted inhibition of intrinsic coagulation limits cerebral injury in stroke without increasing intracerebral hemorrhage. J Exp Med 190:91-99 (Pubitemid 29330126)
15. Choudhri TF, Hoh BL, Zerwes HG et al (1998) Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. J Clin Invest 102:1301-1310 (Pubitemid 28467558)
16. Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139-1151
17. Coutts SB, Goyal M (2009) When recanalization does not improve clinical outcomes. Stroke 40:2661
18. DGN-Leitlinien www.dgn.org/-leitlinien-online.html
19. Dai K, Gao W, Ruan C (2001) The Sma I polymorphism in the von Willebrand factor gene associated with acute ischemic stroke. Thromb Res 104:389-395 (Pubitemid 34084805)
20. Davie EW, Ratnoff OD (1964) Waterfall sequence for intrinsic blood clotting. Science 145:1310-1312
21. Del Zoppo GJ (1998) The role of platelets in ischemic stroke. Neurology 51:S9-S14 (Pubitemid 28429315)
22. Del Zoppo GJ, Mabuchi T (2003) Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab 23:879-894 (Pubitemid 36959394)
23. De Meyer SF, Deckmyn H, Vanhoorelbeke K (2009) von Willebrand factor to the rescue. Blood 113:5049-5057
24. De Meyer SF, Schwarz T, Deckmyn H et al (2010) Binding of von Willebrand factor to collagen and glycoprotein Ibalpha, but not to glycoprotein IIb/IIIa, contributes to ischemic stroke in mice - brief report. Arterioscler Thromb Vasc Biol 30:1949-1951
25. Denis CV, Wagner DD (2007) Platelet adhesion receptors and their ligands in mouse models of thrombosis. Arterioscler Thromb Vasc Biol 27:728-739 (Pubitemid 46606699)
26. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22:391-397 (Pubitemid 29453643)
27. Elvers M, Stegner D, Hagedorn I et al (2010) Impaired alpha (IIb) beta (3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1. Sci Signal 3(103):ra1
28. Esmon CT (2010) Far from the heart: counteracting coagulation. Nat Med 16:759-760
29. Feigin VL, Lawes CMM, Bennett DA et al (2003) Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2:43-53 (Pubitemid 37443343)
30. Feske S (2007) Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 7:690-702 (Pubitemid 47327393)
31. Fujioka M, Hayakawa K, Mishima K et al (2010) ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating post-ischemic hypoperfusion. Blood 115:1650-1653
32. Gailani D, Renné T (2007) Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol 27:2507-2513 (Pubitemid 350158899)
33. Girolami A, Gavasso S, Pacquola E et al (2005) Comparable levels of activity and antigen in factor XII deficiency: a study of 21 homozygotes and 58 heterozygotes. Clin Appl Thromb Hemost 11:335-338 (Pubitemid 41022863)
34. Goerge T, Ho-Tin-Noe B, Carbo C et al (2008) Inflammation induces hemorrhage in thrombocytopenia. Blood 111:4958-4964
35. Govers-Riemslag JW, Smid M, Cooper JA (2007) The plasma kallikrein-kinin system and risk of cardiovascular disease in men. J Thromb Haemost 5:1896-903 (Pubitemid 47288948)
36. Grosse J, Braun A, Varga-Szabo D et al (2007) An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice. J Clin Invest 117:3540-3550 (Pubitemid 350097009)
37. Grüner S, Prostredna M, Schulte V et al (2003) Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo. Blood 102:4021-4027 (Pubitemid 37486984)
38. Hacke W, Furlan AJ, Al-Rawi Y et al (2009) Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion - diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 8:141-150
39. Hagedorn I, Schmidbauer S, Pleines I et al (2010) Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding. Circulation 121:1510-1517
40. Hankey GJ, Eikelboom JW (2010) Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events. Lancet Neurol 9:273-284
41. International Stroke Trial Collaborative Group (1997) The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349:1569-1581
42. Kannemeier C, Shibamiya A, Nakazawa F et al (2007) Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A 104:6388-6393 (Pubitemid 47186104)
43. Kleinschnitz C, Stoll G, Bendszus M et al (2006) Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med 203:513-518
44. Kleinschnitz C, Pozgajova M, Pham M et al (2007) Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation 115:2323-2330 (Pubitemid 46685900)
45. Kleinschnitz C, De Meyer SF, Schwarz T et al (2009) Deficiency of von Willebrand factor protects mice from ischemic stroke. Blood 113:3600-3603
46. Lees KR, Bluhmki E, Kummer R von et al (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375:1695-1703
47. Levy DE, Zoppo GJ del, Demaerschalk BM et al (2009) Ancrod in acute ischemic stroke: results of 500 subjects beginning treatment within 6 hours of stroke onset in the ancrod stroke program. Stroke 40:3796-3803
48. Levy GG, Nichols WC, Lian EC et al (2001) Mutations in a member of the ADAMTS gene family cause thrombo ticthrombocytopenic purpura. Nature 413:488-494 (Pubitemid 32938741)
49. Libersan D, Khalil A, Dagenais P et al (1998) The low molecular weight heparin enoxaparin limits infarct size at reperfusion in the dog. Cardiovasc Res 37:656-666 (Pubitemid 28231160)
50. Macfarlane RG (1964) An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202:498-499
51. Mackman N (2004) Role of tissuefactor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 24:1015-1022 (Pubitemid 38737825)
52. Mary V Wahl F, Uzan A et al (2001) Enoxaparin in experimental stroke: neuroprotection and therapeutic window of opportunity. Stroke 32:993-999 (Pubitemid 32285173)
53. Massberg S, Gawaz M, Grüner S et al (2003) A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 197:41-49 (Pubitemid 36110256)
54. Müller F, Mutch NJ, Schenk WA et al (2009) Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 139:1143-1156
55. Nieswandt B, Schulte V, Bergmeier W (2001) Longterm antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med 193:459-469 (Pubitemid 32524477)
56. Nieswandt B, Watson SP (2003) Platelet-collagen interaction: is GPVI the central receptor? Blood 102:449-461 (Pubitemid 36841960)
57. Nieswandt B Stoll G (2010) The smaller, the better: VWF in stroke. Blood 115:1477-1478
58. Okada Y, Copeland BR, Fitridge R et al (1994) Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. Stroke 25:1847-1853
59. Pfeilschifter W, Spitzer D, Czech-Zechmeister B et al (2011) Increased risk of hemorrhagic transformation in ischemic stroke occurring during warfarin anticoagulation: an experimental study in mice. Stroke 42:1116-1121
60. Pham M, Helluy X, Kleinschnitz C et al (2011) Sustained reperfusion after blockade of glycoproteinreceptor-Ib in focal cerebral ischemia: an MRI study at 17.6 Tesla. PLoS One 6:e18386
61. Pratt J, Boudeau P, Uzan A et al (1998) Enoxaparin reduces cerebral edema after photothrombotic injury in the rat. Haemostasis 28:78-85 (Pubitemid 29152088)
62. Reiner AP, Kumar PN, Schwartz SM et al (2000) Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 31:1628-1633 (Pubitemid 30437514)
63. Renné T, Pozgajová M, Grüner S et al (2005) Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 202:271-281 (Pubitemid 41043823)
64. Rodgers RP, Levin J (1990) A critical reappraisal of the bleeding time. Semin Thromb Hemost 16:1-20 (Pubitemid 20049639)
65. Rosen ED, Chan JC, Idusogie E et al (1997) Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature 390:290-294 (Pubitemid 27513311)
66. Salomon O, Steinberg DM, Koren-Morag N et al (2008) Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood 111:4113-4117
67. Sandercock PA, Counsell C, Kamal AK (2008) Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 8:CD000024
68. Schäbitz WR, Ringelstein EB (Hrsg) (2009) Das stroke unit buch. UNI-MED, Bremen
69. Shinohara Y, Katayama Y, Uchiyama S et al (2010) Cilostazol for prevention of secondary stroke (CSPS2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol 9:959-968
70. Siegerink B, Govers-Riemslag JW, Rosendaal FR et al (2010) Intrinsic coagulation activation and the risk of arterial thrombosis in young women: results from the Risk of Arterial Thrombosis in relation to Oral contraceptives (RATIO) case-control study. Circulation 122:1854-1861
71. Stegner D, Nieswandt B (2010) Platelet receptor signaling in thrombus formation. J Mol Med 89:109-121
72. Stoll G, Kleinschnitz C, Nieswandt B (2008) Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood 112:3555-3562
73. Stoll G, Kleinschnitz C, Nieswandt B (2010) Combating innate inflammation: a new paradigm for acute treatment of stroke? Ann N Y Acad Sci 1207:149-154
74. Schie MC van, Maat MPM de, Isaacs A et al (2011) Variation in the von Willebrand Factor gene is associated with VWF levels and with the risk of cardiovascular disease. Blood 117:1393-1399
75. Varga-Szabo D, Braun A, Kleinschnitz C et al (2008) The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction. J Exp Med 205:1583-1591 (Pubitemid 351962022)
76. Veltkamp R, Hacke W (2011) Neue orale Antikoagulanzien beim Vorhofflimmern. Nervenarzt 82:180-189
77. Vischer UM (2006) Von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost 4:1186-1193
78. Wieberdink RG, Schie MC van, Koudstaal PJ et al (2010) High von Willebrand factor levels increase the risk of stroke. The Rotterdam study. Stroke 41:2151-2156
79. Wu D, Vanhoorelbeke K, Cauwenberghs N et al (2002) Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons. Blood 99:3623-3628 (Pubitemid 34534531)
80. Yanaka K, Spellman SR, McCarthy JB et al (1996) Reduction of brain injury using heparin to inhibit leukocyte accumulation in a rat model of transient focal cerebral ischemia, I: protective mechanism. J Neurosurg 85:1102-1107 (Pubitemid 26396566)
81. Yanaka K, Spellman SR, McCarthy JB et al (1996) Reduction of brain injury using heparin to inhibit leukocyte accumulation in a rat model of transient focal cerebral ischemia, II: dose-response effect and the therapeutic window. J Neurosurg 85:1108-1112 (Pubitemid 26396567)
82. Zhang ZG, Zhang L, Tsang W et al (2001) Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion. Brain Res 912:181-194 (Pubitemid 32800673)
83. Zhao BQ Chauhan AK, Canault M, Patten IS, Yang JJ, Dockal M (2009) von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. Blood 114:3329-3334
84. Zheng X, Chung D, Takayama TK et al (2001) Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 276:41059-41063